THYROCARE — Thyrocare Technologies Income Statement
0.000.00%
Last trade - 00:00
- IN₹33.49bn
- IN₹33.02bn
- IN₹5.27bn
- 98
- 10
- 82
- 74
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,029 | 4,332 | 4,946 | 5,889 | 5,267 |
Cost of Revenue | |||||
Gross Profit | 2,924 | 3,146 | 3,295 | 4,164 | 3,600 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,748 | 2,992 | 3,519 | 3,857 | 4,445 |
Operating Profit | 1,281 | 1,340 | 1,428 | 2,032 | 822 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,381 | 1,404 | 1,525 | 2,277 | 886 |
Provision for Income Taxes | |||||
Net Income After Taxes | 851 | 884 | 1,132 | 1,761 | 644 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 851 | 884 | 1,132 | 1,761 | 645 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 851 | 884 | 1,132 | 1,761 | 644 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 15.8 | 17.5 | 20.5 | 32.9 | 12.3 |
Dividends per Share |